Cigna Group (CI) Stock Forecast & Price Target

Cigna Group
Bear Case

Investors should be bearish about investing in The Cigna Group for these reasons:

• Recent insider activity has been predominantly negative, with insiders selling a total of 23,012 shares worth approximately $6.39 million over the last three months, including a significant sale by CEO David Cordani in May 2026.
• Several prominent research firms have recently downgraded their outlook, with Jefferies Financial Group lowering its rating to "hold" and Raymond James Financial cutting its rating from "strong-buy" to "outperform" in early August 2026, reflecting growing caution among analysts.
• The company's liquidity position is somewhat constrained, with a current ratio of 0.76 and a quick ratio of 0.76, indicating that current liabilities exceed current assets, which may limit flexibility in managing short-term obligations.
• Short interest has increased recently, with shares shorted rising to 5,240,030 as of August 14, 2026, representing a 9.92% month-over-month increase, suggesting that a portion of the market is betting on a price decline.
• The stock has underperformed the broader market over the past year, as noted in recent comparative analyses, despite the company's earnings beats, which may indicate broader market skepticism about its growth trajectory relative to peers.